WRONG! This stock is NOT A "PIG"!!! And Aspire is not a villain!
It's Aspire that's made shareholder wealth possible! All pre-revenue biotech companies have to get funding from somewhere, and IPIX's deal with Aspire has been an excellent choice. Without funding IPIX would not have been able to afford the platform development and clinical trials that make it the company on the threshold of greatness that it is today.
After several days of strength ahead of clinical trial results, IPIX today closed flat on great volume. This is normal and healthy. We all wait release of trial data, expected in just days. There's no legitimate way to cast the past week's price action, or today's, as anything but stellar.
DOTB
News 
Market Data 
Discover 
